TY  - GEN
AU  - Xu,Peng-Peng
AU  - Sun,Yi-Feng
AU  - Fang,Ying
AU  - Song,Qi
AU  - Yan,Zi-Xun
AU  - Chen,Yi
AU  - Jiang,Xu-Feng
AU  - Fei,Xiao-Chun
AU  - Zhao,Yan
AU  - Leboeuf,Christophe
AU  - Li,Biao
AU  - Wang,Chao-Fu
AU  - Janin,Anne
AU  - Wang,Li
AU  - Zhao,Wei-Li
TI  - JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide
SN  - 2045-2322
PY  - 2019///0219
KW  - Animals
KW  - Cell Adhesion Molecules
KW  - genetics
KW  - Cell Line, Tumor
KW  - Disease Progression
KW  - Epithelial-Mesenchymal Transition
KW  - drug effects
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Lenalidomide
KW  - administration & dosage
KW  - Lymphatic Metastasis
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - drug therapy
KW  - Male
KW  - Mice
KW  - Neoplasm Invasiveness
KW  - Nodal Protein
KW  - metabolism
KW  - Prognosis
KW  - Receptors, Cell Surface
KW  - Signal Transduction
KW  - Transforming Growth Factor beta
KW  - Up-Regulation
KW  - Xenograft Model Antitumor Assays
KW  - Zebrafish
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/s41598-017-07964-5
ER  -